Efficacy of fish liver oil and propolis as neuroprotective agents in pilocarpine epileptic rats treated with valproate

Pathophysiology

Volumn 18, Issue 4, 2011, Pages 287-294

  Mannaa, Fathia ^a   El Shamy, Karima A ^a   El Shaikh, Kamal A ^b   El Kassaby, Mahitab ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b Helwan University   (Egypt)

Author keywords

Epilepsy; Fish liver oil; Pilocarpine; Propolis; Rats; Valproate

Indexed keywords

COD LIVER OIL; DOPAMINE; LACTATE DEHYDROGENASE; MASTER; PROPOLIS; SEROTONIN; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; EPILEPSY; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BLOOD LEVEL;

EID: 79960980675     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2011.04.002     Document Type: Article

References (74)

1. Acharya M.M., Hattiangady B., Shetty A.K. Progress in neuroprotective strategies for preventing epilepsy. Prog. Neurobiol. 2008, 84:363-404.
2. Natalio F. Update on classification and terminology of childhood epileptic syndromes. The First Pan African and Pan Arab International Pediatric Epilepsy Conference 2004, 20-21.
3. Frey M. Psychiatric complications of epilepsy in the geriatric patient: diagnostic and treatment considerations. Psychiatric Issues in Epilepsy 2001, Lippincott Williams and Wilkins, New York. A.B. Ettinger, A.M. Kanner (Eds.).
4. Cloyd J., Hauser W., Towne A., Ramsay R., Mattson R., Gilliam F., Walczak T. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res. 2006, 68:39-48.
5. Helen E., Scharfman P. The neurobiology of epilepsy. Curr. Neurol. Neurosci. Rep. 2007, 7:348-354.
6. Ferriero D.M. Protecting neurons. Epilepsia 2005, 46:45-51.
7. Van Den Pol A.N., Obrietan K., Belousov A. Glutamate hyperexcitability and seizure-like activity throughout the brain and spinal cord upon relief from chronic glutamate receptor blockade in culture. Neuroscience 1996, 74:653-674.
8. Fujikawa D.G., Itabashi H.H., Wu A., Shinmei S.S. Status epilepticus-induced neuronal loss in humans without complications or epilepsy. Epilepsia 2000, 41:981-991.
9. Niquet J., Liu H., Wasterlain C.G. Programmed neuronal necrosis and status epilepticus. Epilepsia 2005, 46:43-48.
10. Rao M.S., Hattiangady B., Reddy D.S., Shetty A.K. Hippocampal neurodegeneration, spontaneous seizures, and Mossy fiber sprouting in the F344 rat model of temporal lobe epilepsy. J. Neurosci. Res. 2006, 83:1088-1105.
11. Klitgaard H., Matagne A., Grimee R. Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsy. Seizure 2003, 12:92-100.
12. Pitkanen A Drug-mediated neuroprotection and antiepileptogenesis: animal data. Neurology 2002, 59:27-33.
13. Plant N., Barber E., Horner P., Gibson G., Bugelski P. Differential gene expression in rats following subacute exposure to the anticonvulsant sodium valproate. Toxicol. Appl. Pharmacol. 2002, 183:127-134.
14. Lan M.J., Yuan P., Chen G., Manji H.K. Neuronal peroxisome proliferators-activated receptor gamma signaling: regulation by mood-stabilizer valproate. J. Mol. Neurosci. 2008, 35:225-235.
15. Johannessen C.U. Valproate: past, present, and future. CNS Drug Rev. 2003, 9:199-216.
16. Serrano B.B Valproate population pharmacokinetics in children. J. Clin. Pharmacy Therapeut. 1999, 24:73-80.
17. Fitzpatrick L.A. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav. 2004, 2:51-53.
18. Bartl R. Antiepileptic drug-induced osteopathy. SUBTYPES, pathogenesis, prevention, early diagnosis and treatment. Dtsch Med. Wochenschr. 2007, 132:1475-1479.
19. Pack A.M., Walczak T.S. Bone health in women with epilepsy: clinical features and potential mechanisms. Int. Rev. Neurobiol. 2008, 83:305-328.
20. Akpede G.O., Omotara B.A., Ambe J.P. Rickets and deprivation: a Nigerian study. J. Soc. Health. 1999, 119:216-222.
21. Kehn P., Fernandes G. The importance of omega-3 fatty acids in the attenuation of immune-mediated diseases. J. Clin. Immunol. 2001, 21:99-101.
22. Musiek E.S., Brooks J.D., Joo M., Brunoldi E., Porta A., Zanoni G., Vidari G., Blackwell T.S., Montine T.J., Milne G.L., McLaughlin B., Morrow J.D. Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. J. Biol. Chem. 2008, 283:19927-19935.
23. Ferrari D., Cysneiros R.M., Scorza C.A., Arida R.M., Cavalheiro E.A., de Almeida A.C., Scorza F.A. Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: quantification with immunohistochemical for calcium-binding proteins. Epilepsy Behav. 2008, 13:36-42.
24. Khalil M.L. Biological activity of bee propolis in health and disease. Asian Pac. J. Cancer Prev. 2006, 7:343-348.
25. Inokuchi Y., Shimazawa M., Nakajima Y., Suemori S., Hara H. Brazilian green propolis protects against damage in vitro and in vivo. eCAM 2006, 3:71-77.
26. Turski W.A., Cavalheiro E.A., Bortolotto Z.A., Mello L.M., Schwarez M., Turski L. Seizures produced by pilocarpine in mice: behavioral, electroencephalographic and morphological analysis. Brain Res. 1984, 321:237-253.
27. Williams M.B, Jope R.S. Protein synthesis inhibitors attenuate seizures induced in rats by pilocarpine plus lithium. Exp. Neurol. 1994, 129:169-173.
28. Cavalheiro E.A., Leite J.B., Bortolotto Z.A., Turski W.A., Ikonomidou T., Turski L. Long term effect of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 1991, 32:778-782.
29. Jelińska M., Tokarz A., Oledzka R., Czorniuk-Śliwa A. Effects of dietary linseed, evening primrose or fish oils on fatty acid and prostaglandin E2 contents in the rat livers and 7,12-dimethylbenz[a]anthracene-induced tumors. Biochim. Biophys. Acta 2003, 1637:193-199.
30. Chopra S., Pillai K.K., Husain S.Z., Giri D.K. Propolis protects against doxorubicin-induced myocardiopathy in rats. Exp. Mol. Pathol. 1996, 62:190-198.
31. Sveberg L., Tauboll E., Isojarvi I.T., Pakarinen A.J., Gjerstad L. Effects of chronic valproate treatment on reproductive endocrine hormones in female and male Wister rats. Reprod. Toxicol. 2002, 16:767-773.
32. Schermer S. The Blood Morphology of Laboratory Animals 1967, Philadelphia F.A. Davi Co., 42. 3rd ed.
33. Tsakiris S., Schulpis K.H., Marinou K., Behrakis P. Protective effect of l-cysteine and glutathione on the modulated suckling rat brain Na+-K+ ATPase and Mg+2-ATPase activities induced by the " in vitro" galactoseaemia. Pharmacol. Res. 2004, 49:475-479.
34. Miagkova M.A., Saviskaia I.A., Trubacheva Z.N., Panchenko O.N. Determination of natural antibodies to catecholamines in health and disease. Ter. Arkh. 2001, 70:43-45.
35. Kema I.P. Improved diagnosis of carcinoid tumors by measurement of platelet serotonin. Clin. Chem. 1992, 38:534-540.
36. Ohkawa M., Ruiz-Lorrea M.B., Lacort M. Determination of lipid peroxidation level in brain tissue of epileptic rats. Steroids 1979, 59:383-388.
37. Koracevic D. Hydrogen peroxide direct method for the " in vitro" determination of total antioxidant capacity in serum. J. Clin. Pathol. 2001, 54:356-361.
38. Buhl S.N., Jackson K.Y. For the quantitative determination of lactate dehydrogenase in serum. Clin. Chem. 1978, 24:828.
39. Duncan D.B. Multiple ranges and multiple F-test. Biometrics 1955, 1-42.
40. Costello D.J., Delanty N. Oxidative injury in epilepsy: potential for antioxidant therapy. Expert. Rev. Neurotherapeut. 2004, 4:541-553.
41. Al-Tajir G., Chandler C.J., Starr B.S., Starr M.S. Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat. Neuropharmacology 1990, 29:657-661.
42. Ferraro G., Vella N., Sardo P., Caravaglios G., Sabatino M., LaGiuta V. Dopaminergic control of feline hippocampal epilepsy, a nigro hipocampal pathway. Neurosci. Lett. 1991, 123:41-44.
43. Dowdall M., Montigny C. Effects of atmospheric ions on hippocampal pyramidal neuron responsiveness to serotonin. Brain Res. 1985, 342:103-109.
44. Clinckers R., Smolders I., Meurs A., Ebinger G., Michtte Y. Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors. Neurochemistry 2004, 89:834-843.
45. Baf M.H., Subhash M.N., Lakshmana K.M., Rao B.S. Sodium valproate induced alterations in monoamine levels in different regions of rat brain. Neurochemistry 1994, 24:67-72.
46. Lauritzen I., Blondeau N., Heurteaux C., Widmann C., Romey G., Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. Eur. Mol. Biol. Org. J. 2000, 19:1784-1793.
47. Puskas L.G., Kitajka K., Nyakas C., Barcelo-Coblijn G., Farkas T. Sort-term administration of omega 3 fatty acids from fish liver oil results in increased trasthyretin transcription in old rat hippocampus. PNAS 2002, 100:1580-1585.
48. Shimazawa M., Chikamatsu S., Morimoto N., Mishima S., Nagai H., Hara H. Neuroprotection by Brazilian green propolis against in vitro and in vivo ischemic neuronal damage. Evid. Based Complem. Alternat. Med. 2005, 2:201-207.
49. Ueda H., Yokoyama R., Niwa R., Konaka H., Kamada H. Generation of lipid radicals in the hippocampal extracellular space during Kainic acid-induced seizures in rats. Epilepsy Res. 1997, 26:329-333.
50. Frantseva M.V., Velazquez J.L., Hwang P.A., Carlen P.L. Free radical production correlates with cell death in an in vitro model of epilepsy. Eur. J. Neurosci. 2000, 12:1431-1439.
51. Sudha K., Rao A.V., Rao A. Oxidative stress and antioxidants in epilepsy. Clin. Chim. Acta 2001, 303:19-24.
52. Oliver C.N., Strake-Reed P.E., Stadtman E.R., Lin G.J., Correy J.M., Floyd R.A. Oxidative damage to brain proteins, loss of glutamine synthetase activity and production of free radicals during ischemia/reperfusion induced injury to gerbil brain, Proc. Natl. Acad. Sci. U.S.A. 1990, 87:5144-5147.
53. Halliwell B., Gutteridge M.C. Oxygen is poisonous: an introduction to oxygen toxicity and free radicals. Free Radicals in Biology and Medicine 1991, 1-20. Clarendon Press, Oxford. B. Halliwell, M.C. Gutteridge (Eds.).
54. Price J.L. Prefrontal cortical networks related to visceral functional and mood. Ann. N.Y. Acad. Sci. 1999, 383-396.
55. Wang J.F., Azzam J.E., Young L.T. Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells. Neuroscience 2003, 116:485-489.
56. Shao L., Young T., Wang J. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Neuroscience 2005, 43:1173-1179.
57. Mete N., Isik B., Erdinc L., Gurkan F. The effect of fish oil on liver and plasma MDA and antioxidant status of rats. J. Med. Sci. 1997, 29:1-6.
58. Marquele F.D., Stracieri K.M., Fonseca M.J., Freitas L.A. Spray-dried propolis extract. I: physicochemical and antioxidant properties. Pharmazie 2006, 61:325-330.
59. Padmavathi R., Senthinathan P., Chodon D., Sakthisekaran D. Therapeutic effect of paclitaxel and propolis on lipid peroxidation and antioxidant system in 7,12 dimethyl benz (a) anthracene-induced breast cancer in female Sprague Dawley rats. Life Sci. 2006, 78:2820-2825.
60. Shimizu K., Ashida H., Matsuura Y., Kanazawa K. Antioxidant bioavailability of artepillin C in Brazilian propels. Arch. Biochem. Biophys. 2004, 424:181-188.
61. Turkyilmaz S., Alhan E., Ercin C., Kural Vanizor B., Kaklikkaya N., Ates B., Erdogan S., Topaloglu S. Effects of caffeic acid phenethyl ester on pancreatitis in rats. J. Surg. Res. 2008, 145:19-24.
62. Turski W.A., Cavalheiro E.A., Schwarz M., Kleinrok Z., Turski L. Limbic seizures produced by pilocarpine in rats: behavioral, electrographic and neuropathophysiological study. Behav. Brain Res. 1983, 9:315-335.
63. Fernandes M.J.S, Naffah-Mazzacoratti M.G., Cavalheiro E.A. Na+/K+-ATPase activity in the rat hippocampus: a study in the pilocarpine model of epilepsy. Neurochem. Int. 1996, 28:497-500.
64. Turner N., Else P.L., Hulbert A.J. Docosahexanoic acid (DHA) content of membranes determines molecular activity of the sodium pump: implications for disease states and metabolism. Naturwissenschaften 2003, 90:521-523.
65. Gerbi A., Maixent J., Ansaldi J., Pierlovisi A., Coste T., Vague P. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats. J. Nutr. 1999, 129:207-213.
66. Haag M., Magada O.N., Claassen N., Kruger M.C. Omega-3 fatty acids modulate ATPases in duodenal Ca absorption, prostaglandins Leukot. Essen. Fatty Acids 2003, 68:423-429.
67. Koksel O., Kaplan M.B., Ozdulger A., Tamer L., Cinel L. Oleic acid-induced lung injury in rats and effects of caffeic acid phenyl ester. Exp. Lung Res. 2005, 31:483-496.
68. Erakovic V., Zupan G., Varljen J., Laginja J. Altered activities of rat brain metabolic enzymes in electroconvulsive Shoch-induced seizures. Epilepsia 2001, 42:181-189.
69. Attilakos A., Voudris K.A., Garoufi A., Dimou S. Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study. Eur. J. Pediatr. Neurol. 2006, 10:237-240.
70. Sugimoto T., Muro H., Woo M., Nishida N., Murakami K. Valproate metabolites in high-dose valproate plus phenytoin therapy. Epilepsia 1996, 37:1200-1203.
71. Schauder P., Rohn U., Schafer G., Korff G., Schenk H. Impact of fish oil enriched total parenteral nutrition on DNA synthesis, cytokine release and receptor expression by lymphocytes in the postoperative period. Br. J. Nutr. 2002, 87:103-110.
72. Castro S.L Propolis: biological and pharmacological activities. Therapeutic uses of this bee-product. Ann. Rev. Biomed. Sci. 2001, 3:49-83.
73. Gao M., Zhang W.C., Liu Q.S., Hu J.J., Liu G.T., Du G.H. Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2 ratio. Eur. J. Pharmacol. 2008, 591:73-79.
74. Sforcin J.M., Novelli E.L., Funari S.R. Seasonal effect of Brazilian propolis on seric biochemical variables. J. Venamous Animals Toxins 2002, 8:244-254.